JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scavone, C.
Right arrow Articles by Nathanson, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scavone, C.
Right arrow Articles by Nathanson, J. A.

Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase

C Scavone, C Scanlon, M McKee and JA Nathanson

Department of Neurology, Harvard Medical School, Boston, Massachusetts.

Prior studies indicate that the natriuretic effects of atrial natriuretic peptide (ANP) are due, in part, to an inhibition of the passive movement of sodium ions from tubular lumen through apical cation channels into renal tubular epithelium. The present work demonstrates that ANP also exerts a potent inhibitory effect on the active pumping of sodium ions by renal tubular sodium and potassium- activated adenosine triphosphatase (Na, K-ATPase). This action of ANP is relatively long lasting, is due to a change in enzyme Vmax and is specific for ouabain-sensitive activity. Enzyme modulation occurs with an EC50 for ANP of 0.1 nM, is independent of intracellular [Na+] and is associated with an increase in tissue cyclic GMP (cGMP), but not cyclic AMP (cAMP). Modulation of Na, K-ATPase by ANP is mimicked by 8-bromo- cGMP and okadaic acid (OA) and is blocked by KT 5823, a selective inhibitor of cGMP-dependent protein kinase (PKG), but not by KT 5720, a selective inhibitor of cyclic AMP-dependent protein kinase (PKA), which suggests that the action of ANP on the sodium pump involves cGMP- mediated changes in protein phosphorylation. Regulation of renal Na, K- ATPase activity also occurs with nitric oxide-generating compounds, such as nitroglycerin and sodium nitroprusside (SNP). However, the ability of ANP to modulate Na, K-ATPase does not appear to involve this latter pathway because the effects of ANP on the sodium pump cannot be blocked by either N omega-nitro-L-arginine, an inhibitor of NO synthase, or hemoglobin, which blocks NO through binding.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 272, Issue 3, pp. 1036-1043, 03/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
W. M. Dismuke, C. C. Mbadugha, and D. Z. Ellis
NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1378 - C1386.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. William, E. J. Hamilton, A. Garcia, H. Bundgaard, K. K. M. Chia, G. A. Figtree, and H. H. Rasmussen
Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activation
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1067 - C1073.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Kotlo, S. Shukla, U. Tawar, R. A. Skidgel, and R. S. Danziger
Aminopeptidase N reduces basolateral Na+-K+-ATPase in proximal tubule cells
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1047 - F1053.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
O. V. Fedorova, N. I. Agalakova, C. H. Morrell, E. G. Lakatta, and A. Y. Bagrov
ANP Differentially Modulates Marinobufagenin-Induced Sodium Pump Inhibition in Kidney and Aorta
Hypertension, December 1, 2006; 48(6): 1160 - 1168.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
C. K. Tipsmark and S. S. Madsen
Regulation of Na+/K+-ATPase activity by nitric oxide in the kidney and gill of the brown trout (Salmo trutta)
J. Exp. Biol., May 1, 2003; 206(9): 1503 - 1510.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Z. Ellis, J. Rabe, and K. J. Sweadner
Global Loss of Na,K-ATPase and Its Nitric Oxide-Mediated Regulation in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
J. Neurosci., January 1, 2003; 23(1): 43 - 51.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Z. Ellis, J. A. Nathanson, and K. J. Sweadner
Carbachol inhibits Na+-K+-ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway
Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1685 - C1693.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. G. Therien and R. Blostein
Mechanisms of sodium pump regulation
Am J Physiol Cell Physiol, September 1, 2000; 279(3): C541 - C566.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. SENGENÈS, M. BERLAN, I. DE GLISEZINSKI, M. LAFONTAN, and J. GALITZKY
Natriuretic peptides: a new lipolytic pathway in human adipocytes
FASEB J, July 1, 2000; 14(10): 1345 - 1351.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Blanco and R. W. Mercer
Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function
Am J Physiol Renal Physiol, November 1, 1998; 275(5): F633 - F650.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics.